Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FeelGood vs NuviaRx

FeelGood
Graded #120

Lower grade

vs+4
NuviaRx
Graded #69

Higher grade

The verdict

NuviaRx takes it — 73.5/100 to 69.5/100.

NuviaRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuviaRx is a GLP-1 weight-loss telehealth service offering compounded semaglutide (from $140/mo) and tirzepatide (from $170/mo) with transparent pricing and free delivery.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuviaRx +7
80
87
Dose & formulationNuviaRx +8
64
72
Clinical oversightNuviaRx +3
79
82
Labs & monitoringEven
53
53
FulfillmentNuviaRx +1
71
72
Contract termsEven
55
55
FeelGood · left barNuviaRx · right bar

The numbers

MetricFeelGoodNuviaRx
WeighScore69.5/10073.5/100
GradeCC
Scorecard rank#120#69
SemaglutideNot disclosed$140/mo (all doses, compounded)
TirzepatideNot disclosed$170/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
FeelGood

Graded #120 · C

Strengths

  • Both compounded semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) formulations available
  • Low compounded injection entry price ($149/mo) with no membership or hidden fees
  • Oral/dissolvable tablet option for needle-averse patients
  • LegitScript-certified site (seal #247923); OpenLoop Health telehealth backbone
  • Free shipping and HSA/FSA eligibility

Where it loses points

  • State availability not publicly disclosed on the site
  • Compounding pharmacy partner not named publicly ("US-certified pharmacy" only)
  • Brand-name ("Original") injections are expensive at $1,999/mo and limited in availability
NuviaRx

Graded #69 · C

Strengths

  • Transparent, affordable pricing — compounded semaglutide from $140/mo, tirzepatide from $170/mo
  • Free delivery included; clinical evaluation and prescription bundled (if eligible)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Informed Consent, Medical Disclaimer)
  • Named operating entity (NuviaRx Health Inc.) with a US address and phone support

Where it loses points

  • Compounding pharmacy partner not named ('partner pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Lowest pricing is 'as low as' — likely requires a longer prepaid plan
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard